Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05075564
Title A Study of ES002023 (Anti-CD39 Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Elpiscience Biopharma, Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Scottsdale Arizona 85258 United States Details
Fayetteville Oncology Fayetteville Arkansas 72703 United States Details
UCLA Los Angeles California 90095 United States Details
Sarah Cannon Research Institute Orlando Florida 32827 United States Details
Cancer Institute of New Jersey New Brunswick New Jersey 08901 United States Details
NEXT Austin Austin Texas 78758 United States Details
NEXT Virginia Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field